Kent Imaging

02/20/2026

Successful clinical training with the Brevard Regional Hyperbaric Center team and Dr. Tyler Sexton, MD, MAPWCA.

Eric Hirabayashi and Dr. Chris Barrett, DPM, were on deck to support the Brevard providers!

Great work all around!

02/19/2026

Kent Imaging Celebrates 20 Years of MedTech Innovation

Kent Imaging, a pioneer in near-infrared spectroscopy (NIRS) medical imaging devices, is proud to celebrate their 20-year anniversary. Kent Imaging was formed in 2006, working on the commercialization of a research concept initially developed at the National Research Council of Canada (NRC). Over the 20-year period since its inception, Kent Imaging has evolved into an innovative leader in tissue assessment and wound care imaging.

“Two decades in MedTech is a testament to our endurance, purpose, and collaboration,” said Pierre Lemire, Chief Executive Officer of Kent Imaging. “We are proud to have built this company in Calgary from day one—navigating complex regulatory pathways, clinical validation, and global market expansion—while staying true to our mission of improving patient outcomes. This milestone is also a tribute to Don, whose vision continues to guide our work every day.”

Will Hall, Chief Executive Officer of New Horizon Medical Solutions, commented, "Kent Imaging has spent two decades earning the trust of clinicians worldwide — and that track record is exactly why we chose them as a partner. We look forward to building on that foundation together.”

"Kent Imaging represents the best of Canadian innovation—ambition, resilience, and a commitment to building solutions that matter," said Dr. Luc Marengère, interim Chairman of the Board for Kent Imaging and Managing Partner at TVM Life Science. "As they scale globally, their impact is felt across the province and continues to strengthen the local tech sector.”

Read the full press release: https://hubs.la/Q043QH9m0

02/18/2026

Kent Imaging is headed to the CAMPs Wound Care Summit 2026!

We’re excited to be exhibiting at this year’s Cellular, Acellular, and Matrix‑Like Products (CAMPs) Wound Care Summit, hosted by the Journal of Wound Care, on March 6–7, 2026 in West Palm Beach, FL.

📍 Visit us at Booth #1

Our team will be showcasing SnapshotNIR and SnapshotGLO, two imaging tools that empower clinicians with real‑time insight into tissue viability, oxygenation status, and bacterial bioburden.

Find out more: https://hubs.la/Q042x8tm0

Will we see you there?

02/17/2026

What if you could objectively monitor the application of advanced therapies like CAMPs?

In this case series, Dr. Naz Wahab uses SnapshotNIR imaging to track ongoing progress during serial Kerecis CAMPs applications to assess wound bed oxygenation in patients with nutritional skin failure and significant vascular disease.

The ability to visualize changes in oxygenation over time helped confirm treatment response and supported the wound‑healing algorithm.

🔍 Explore the full case study for clinical insight into combining advanced therapies with NIRS imaging.

👉 Access the case study https://hubs.la/Q040nvDT0

02/13/2026

Exciting collaborations that continue to push the envelope for elevating the standard of care for wounds.

Jeffrey Alan Niezgoda, MD, FACHM, MAPWCA, CHWS, Chief Medical Officer of Kent Imaging and board member of NHMS, stated, "The use of SONOCA 185 and the UAW instruments for Ultrasonic Wound Debridement guided by SnapshotGLO and monitored by SnapshotNIR, can significantly improve wound management and lead to better patient outcomes. These devices synergistically optimize wound bed preparation prior to CAMPs application."

Will Hall, CEO of New Horizon Medical Solutions, added, "This collaboration reflects our belief that the future of wound care lies in combining advanced technology with evidence-based clinical solutions. By bringing Söring's ultrasonic system into our portfolio, we're expanding access to innovative tools that address critical gaps in treatment while improving efficiency and outcomes across care settings."

Read the press release:

February 9, 2026 -- New Horizon Medical Solutions a leader in advanced wound care technologies, announces a new strategic collaboration with Soring, the U.S. affiliate of Söring (Germany) for the sale of their cutting-edge Ultrasonic Wound Debridement (UAW) device.

02/12/2026

“A significant advantage of NIRS is its ability to quantify tissue oxygen saturation directly in and around the wound in a non-invasive and non-contact manner. This small, prospective exploratory study indicates that NIRS is a rapid, efficient, and practical method for assessing surrogate parameters of wound perfusion and estimating healing tendencies in CLTI patients post-EVT. NIRS is particularly reliable for low-risk wounds with small or no areas of gangrene/necrosis, which are common in clinical practice.”

Want a quick reference to all the important publications for NIR? Download here: https://hubs.la/Q042JgD00

Figure 5. Reproduced from Impact of Peripheral Angioplasty on Wound Oxygenation and Healing in Patients with Chronic Limb-Threatening Ischemia Measured by Near-Infrared Spectroscopy by Schremmer et al., 2024, published in Biomedicines, © 2024 by the authors. Licensed under CC BY 4.0 (https://hubs.la/Q042JgTq0). Source: https://hubs.la/Q042Jhm40.

Publication citation: Schremmer, J., Stern, M., Baasen, S., Wischmann, P., Foerster, R., Schillings, M., Bódis, K., Sansone, R., Heiss, C., Kelm, M., & Busch, L. (2024). Impact of Peripheral Angioplasty on Wound Oxygenation and Healing in Patients with Chronic Limb-Threatening Ischemia Measured by Near-Infrared Spectroscopy. *Biomedicines*, *12*(8), 1805. https://doi.org/10.3390/biomedicines12081805

02/10/2026

Are all NIRS devices the same?

They are not.

With SnapshotNIR, you get side-by-side comparison which allows the clinician to compare pre- and post-intervention images, you can compare baseline and progress images, or you can view the photograph of the wound and the tissue oxygenation images.

Markers on SnapshotNIR will appear in all 4 panels of Hemoglobin view and clinicians aren’t limited by number.

When it comes to real-time tissue oxygenation imaging, screen size matters—and SnapshotNIR delivers.

Want to dive further into the differences between NIRS medical imaging devices on the market?

Watch the NIRS Clinical Connection Episode 9 with Dr. Jeffrey A. Niezogda, Kent Imaging’s Wound Care CMO, on demand: https://hubs.ly/Q042n75N0

02/05/2026

Using NIRS for oxygenation monitoring in Chronic Limb-Threatening Ischemia

This exploratory study's results "suggest that NIRS is a practical, rapid, and efficient method for assessing wound perfusion and healing tendencies in CLTI patients, offering advantages over the traditional ABI, which did not reliably correlate with wound healing in this study."

Read the full publication here: https://hubs.la/Q041QRb90

Schremmer, J.; Stern, M.; Baasen, S.; Wischmann, P.; Foerster, R.; Schillings, M.; Bódis, K.; Sansone, R.; Heiss, C.; Kelm, M.; et al. Impact of Peripheral Angioplasty on Wound Oxygenation and Healing in Patients with Chronic Limb-Threatening Ischemia Measured by Near-Infrared Spectroscopy. Biomedicines 2024, 12,1805. https://hubs.la/Q041QR0-0 biomedicines12081805

02/04/2026

We’re excited for this Friday — MediMax Global UK Ltd. will be showcasing SnapshotNIR at the 19th National Wound Care Conference in London!

This premier event, hosted by the Journal of Wound Care in collaboration with MA Healthcare, brings together leading clinicians, researchers, and innovators to shape the future of wound care.

Look for MediMax this Friday, 6 February 2026, at the iconic Minster Building to learn about SnapshotNIR and connect with the incredible wound care community in the UK!

Learn more: https://hubs.la/Q041Bqbh0

01/29/2026

Missed the Wounds Week webinar last week? You can now watch the session on demand!

Kent Imaging was proud to sponsor this session, supporting continued education and clinical discussion in wound care.

▶️ Watch the webinar on demand here: https://hubs.la/Q040pKDP0

01/27/2026

Managing nutritional skin failure is complex—especially when tissue viability is difficult to assess.

In this clinical case series, Dr. Naz Wahab, MD, shares how applications of Kerecis CAMPs were supported by SnapshotNIR near‑infrared spectroscopy to objectively monitor tissue oxygenation and wound response over time.

Access the full case study to see how objective oxygenation data supported clinical decision‑making in these complex wounds.

👉 Download the case study https://hubs.la/Q040nwBl0

01/20/2026

Kent Imaging has issued a statement regarding the complaint filed by MolecuLight Corp. and MolecuLight Inc. in the U.S. International Trade Commission (ITC). The complaint alleges that Kent Imaging's SnapshotGLO®, which recently received FDA 510(k) clearance, infringes a patent to which MolecuLight purports to have a license. Kent Imaging denies all allegations of patent infringement in the complaint and is confident that MolecuLight's claims are without merit. Underscored by its track record for innovation, Kent Imaging maintains the highest respect for the intellectual property rights of others and intends to defend itself fully and fiercely against MolecuLight's unfounded claims.

The ITC action is pending and there has been no ruling or judgement by the ITC.

Read the press release: https://hubs.la/Q03_nN1-0